UTOPIA SIS S.p.A.
UTOPIA SOCIETA’ DI INVESTIMENTO SEMPLICE aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.
What is a SIS
SOCIETA’ DI INVESTIMENTO SEMPLICE (SIS) is a Venture Capital vehicle aimed at investing in start-ups and unlisted SMEs and subject to a subsidized regime.
Our Focus
DISEASE MODIFYING DRUGS
CROSS BORDER CON ARTIFICIAL INTELLIGENCE
MEDICAL DEVICES
DIAGNOSTIC TOOLS AND BIOMARKERS
Latest News
Utopia SIS and Pariter Partners invest in Lighthouse Biotech
Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 - Utopia SIS, an investment company...
Alfasigma, Utopia SIS, Istituto David Chiossone e Club2021 (famiglia Taini) entrano nella start-up Novavido
The 6 million euro round is underway with two tranches of capital increase of the start-up already accelerated by G-Factor of the Golinelli Foundation and developed thanks to the scientific research of IIT and the Don Calabria Hospital in Negrar. The project focuses...